5-(4-Phenoxybutoxy)psoralen
SIGMA/P6124 - ≥98% (HPLC), solid
Synonym: PAP-1
CAS Number: 870653-45-5
Empirical Formula (Hill Notation): C21H18O5
Molecular Weight: 350.36
MDL Number: MFCD11114059
Linear Formula: C21H18O5
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white |
| form | solid |
| InChI | 1S/C21H18O5/c22-20-9-8-16 |
| InChI key | KINMYBBFQRSVLL-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | O=C1Oc2cc3occc3c(OCCCCOc4 |
| solubility | DMSO: 9 mg/mL |
| storage condition | protect from light |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | 5-(4-Phenoxybutoxy)psoral |
| Biochem/physiol Actions: | Selective inhibitor of Kv1.3, voltage-gated K+ channel. |
| Biochem/physiol Actions: | Selective inhibitor of Kv1.3, voltage-gated K+ channel. PAP-1 (EC50=2 nM) potently inhibits human T effector memory cell proliferation and delayed hypersensitivity. Effective orally or intraperitoneally. 5-(4-Phenoxybutoxy)psoral |
| Features and Benefits: | This compound is featured on the Potassium Channels page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | GHS08 |
| Signal word | Danger |
| Hazard statements | H334 |
| Precautionary statements | P261 - P342 + P311 |
| Risk Statements | 42/43 |
| Safety Statements | 22-36/37-45 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |


